NCT03098940View on ClinicalTrials.gov

A Bioavailability Study on Dronabinol

PHASE1UnknownINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2018

Primary Completion Date

April 30, 2018

Study Completion Date

September 30, 2018

Conditions
THC
Interventions
DRUG

Chewing Gum

During the study healthy subjects will receive single doses of the various strengths of dronabinol

Sponsors
All Listed Sponsors
lead

Axim Biotechnologies

INDUSTRY

NCT03098940 - A Bioavailability Study on Dronabinol | Biotech Hunter | Biotech Hunter